Abstract
IntroductionRandomised controlled trials (RCTs) may use surrogate endpoints as substitutes and predictors of patient-relevant/participant-relevant final outcomes (eg, survival, health-related quality of life). Translation of effects measured on a surrogate endpoint...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have